It looks like something’s cooking. It has the part regarding Leo’s salary and performance plan…
“…with a maximum value of up to $35.0 million, contingent upon the achievement of certain market capitalization, licensing revenue and clinical trial performance goals, and (ii) cash awards with a maximum value of up to $14.0 million, contingent upon the achievement of certain market capitalization and licensing revenue goals.”
…and compensation awa4ds for directors.
There’s no protection for Leo if the stock doesn’t perform.
Market Data 
Markets 
AI
